Literature DB >> 7540206

Expression of estrogen receptor related protein (p29) and estradiol binding in human arthritic synovium.

T Ushiyama1, K Inoue, J Nishioka.   

Abstract

OBJECTIVE: We investigated the expression of estrogen receptors (ER) and the presence of estradiol in human synovial tissues from subjects without arthritis and patients with traumatic arthritis, osteoarthritis, and rheumatoid arthritis.
METHODS: Synovial tissues were immunostained using ER-D5 monoclonal antibody (Mab) directed toward an ER related protein (p29), ER-ICA Mab directed toward nuclear ER, and antiestradiol serum. Fluorescent estradiol was used to demonstrate specific estradiol binding to ER.
RESULTS: (1) p29 was present predominantly in hyperplastic synovial lining cells and smooth muscles of blood vessels. (2) Exogenous estradiol bound to synoviocytes and sublining macrophage-like cells in the inflamed synovium. (3) Endogenous estradiol was also detected in hyperplastic lining cells and macrophage-like cells in arthritic synovium.
CONCLUSION: Our study demonstrated the expression of ER in arthritic synovium and suggested that estrogen modulates local inflammation in various joint diseases via synoviocytes as well as sublining macrophage-like cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7540206

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  8 in total

Review 1.  Recent aspects of gonadal hormone and neurotransmitter interactions with synovial and immune cells: implications in rheumatoid arthritis.

Authors:  M Cutolo; R H Straub
Journal:  Ann Rheum Dis       Date:  2000-09       Impact factor: 19.103

2.  Association of oestrogen receptor gene polymorphisms with age at onset of rheumatoid arthritis.

Authors:  T Ushiyama; K Mori; K Inoue; J Huang; J Nishioka; S Hukuda
Journal:  Ann Rheum Dis       Date:  1999-01       Impact factor: 19.103

3.  The role of osteoprotegerin (OPG) and estrogen receptor (ER-α) gene polymorphisms in rheumatoid arthritis.

Authors:  Laura Masi; Susanna Maddali Bongi; Chiara Angotti; Francesca Del Monte; Silvia Carbonell Sala; Massimo Basetti; Antonietta Amedei; Alberto Falchetti; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2007-05

Review 4.  Management of complications from estrogen deprivation in breast cancer patients.

Authors:  Dawn L Hershman; Christina Cho; Katherine D Crew
Journal:  Curr Oncol Rep       Date:  2009-01       Impact factor: 5.075

5.  Raloxifene reduces urokinase-type plasminogen activator-dependent proliferation of synoviocytes from patients with rheumatoid arthritis.

Authors:  S Guiducci; A Del Rosso; M Cinelli; F Perfetto; R Livi; A Rossi; A Gabrielli; R Giacomelli; N Iori; G Fibbi; M Del Rosso; M Matucci Cerinic
Journal:  Arthritis Res Ther       Date:  2005-09-08       Impact factor: 5.156

6.  Relaxin and beta-estradiol modulate targeted matrix degradation in specific synovial joint fibrocartilages: progesterone prevents matrix loss.

Authors:  Gihan Hashem; Qin Zhang; Takayuki Hayami; Jean Chen; Wei Wang; Sunil Kapila
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

7.  The utility of pathway selective estrogen receptor ligands that inhibit nuclear factor-kappa B transcriptional activity in models of rheumatoid arthritis.

Authors:  James C Keith; Leo M Albert; Yelena Leathurby; Max Follettie; Lili Wang; Lisa Borges-Marcucci; Christopher C Chadwick; Robert J Steffan; Douglas C Harnish
Journal:  Arthritis Res Ther       Date:  2005-02-21       Impact factor: 5.156

8.  Estrogen and inflammation modulate estrogen receptor alpha expression in specific tissues of the temporomandibular joint.

Authors:  Jyoti Puri; Bob Hutchins; Larry L Bellinger; Phillip R Kramer
Journal:  Reprod Biol Endocrinol       Date:  2009-12-31       Impact factor: 5.211

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.